DXCM - DEXCOM INC

62.6
-2.020   -3.227%

Share volume: 4,075,598
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$64.62
-2.02
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 18%
Dept financing 42%
Liquidity 68%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.16%
1 Month
-5.07%
3 Months
-15.31%
6 Months
-11.46%
1 Year
-5.62%
2 Year
-52.40%
Key data
Stock price
$62.60
P/E Ratio 
30.95
DAY RANGE
$62.41 - $65.00
EPS 
$2.14
52 WEEK RANGE
$54.11 - $89.98
52 WEEK CHANGE
-$6.37
MARKET CAP 
25.885 B
YIELD 
N/A
SHARES OUTSTANDING 
384.865 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.84
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,362,309
AVERAGE 30 VOLUME 
$4,004,848
Company detail
CEO: Kevin R. Sayer
Region: US
Website: dexcom.com
Employees: 7,600
IPO year: 2005
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.

Recent news